Phase 2 Relapsed Follicular Lymphoma Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy
Refractory Follicular LymphomaRelapsed Follicular Lymphoma
University of Birmingham284 enrolled25 locationsNCT05848765
Completed
Phase 2
A Phase 2 Study of patients treated for relapsed Follicular Lymphoma: with Revlimid (Registered Trademark) consolidation added to Rituximab maintenance therapy in those remaining Positron Emission Tomography (PET) positive (ALLG NHL26)
Relapsed Follicular Lymphoma
Australasian Leukaemia and Lymphoma Group80 enrolled11 locationsACTRN12613000106730